Heron Therapeutics, Inc.Heron Therapeutics, Inc.Heron Therapeutics, Inc.

Heron Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪416.41 M‬USD
−0.87USD
‪−110.56 M‬USD
‪127.04 M‬USD
‪142.67 M‬
Beta (1Y)
2.70

About Heron Therapeutics, Inc.

CEO
Craig A. Collard
Headquarters
San Diego
Employees (FY)
126
Founded
1983
ISIN
US4277461020
FIGI
BBG000G2GJT7
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HRTX is 2.71 USD — it has decreased by 2.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Heron Therapeutics, Inc. stocks are traded under the ticker HRTX.
Heron Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
HRTX stock is 9.83% volatile and has beta coefficient of 2.70. Check out the list of the most volatile stocks — is Heron Therapeutics, Inc. there?
One year price forecast for Heron Therapeutics, Inc. has a max estimate of 9.00 USD and a min estimate of 5.00 USD.
HRTX earnings for the last quarter are −0.17 USD whereas the estimation was −0.29 USD which accounts for 41.88% surprise. Estimated earnings for the next quarter are −0.15 USD. See more details about Heron Therapeutics, Inc. earnings.
Heron Therapeutics, Inc. revenue for the last quarter amounts to ‪31.43 M‬ USD despite the estimated figure of ‪32.65 M‬ USD. In the next quarter revenue is expected to reach ‪31.23 M‬ USD.
Yes, you can track Heron Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
HRTX stock hasn't changed in a week, the month change is a 8.14% fall, over the last year Heron Therapeutics, Inc. has showed a 3.04% increase.
HRTX net income for the last quarter is ‪−10.72 M‬ USD, while the quarter before that showed ‪−25.01 M‬ USD of net income which accounts for 57.12% change. Track more Heron Therapeutics, Inc. financial stats to get the full picture.
Today Heron Therapeutics, Inc. has the market capitalization of ‪416.41 M‬, it has increased by 7.84% over the last week.
No, HRTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HRTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Heron Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
HRTX reached its all-time high on Jan 13, 1992 with the price of 1290.00 USD, and its all-time low was 0.50 USD and was reached on Nov 9, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 126.00 employees. See our rating of the largest employees — is Heron Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Heron Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Heron Therapeutics, Inc. stock shows the sell signal. See more of Heron Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Heron Therapeutics, Inc. future price: according to them, HRTX price has a max estimate of 9.00 USD and a min estimate of 5.00 USD. Read a more detailed Heron Therapeutics, Inc. forecast: see what analysts think of Heron Therapeutics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Heron Therapeutics, Inc. EBITDA is ‪−107.72 M‬ USD, and current EBITDA margin is −84.79%. See more stats in Heron Therapeutics, Inc. financial statements.